Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02136004 · ClinicalTrials.gov registry record · NA

The Closer Trial: A Safety and Efficacy Study of the Rex Medical Vascular Sealing System

A NA study of Surgical Wound, sponsored by Rex Medical.

Completed
Registry status
NA
Development phase
220
Enrollment target
12
Study locations

NCT02136004: Completed NA study of Surgical Wound, sponsored by Rex Medical.

NCT02136004 is a NA study of Surgical Wound that has completed, run by Rex Medical. The registered enrollment target is 220 participants, above the 82-participant average among 17 other Surgical Wound trials with a reported enrollment target (168% higher). The trial reports 12 study locations across 10 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02136004, a NA study of Surgical Wound, has completed, sponsored by Rex Medical.

COMPLETED
Registry status
NA
Development phase
220 participants
Enrollment target
12
Study locations

Study Summary

The objective of this trial is to demonstrate the safety and effectiveness of the Rex Medical Closer Vascular Sealing System in sealing femoral arterial access sites.

Primary Outcome

Primary effectiveness endpoint - elapsed time between the Closer VSS delivery system removal and first observed and confirmed arterial hemostasis

Conditions Studied

Interventions

  • DEVICE Closer VSS

Study Locations (12)

Pennsylvania

  • Geisinger Health Center - Danville
  • Geisinger Health Center - Wilkes-Barre
  • Pinnacle Health - Wormleysburg

California

  • UC Davis Medical Center - Sacramento

Colorado

  • Colorado Neurological Institute - Englewood

District of Columbia

  • Washington Hospital Center - Washington D.C.

Louisiana

  • Lafayette General Medical Center/Cardiovascular Institute of the South - Lafayette

New York

  • New York Presbyterian Hospital - New York

Ohio

  • North Ohio Research - Elyria

Oklahoma

  • Oklahoma Heart Institute - Tulsa

Trial Details

FieldValue
Enrollment Target 220 participants
Start Date 2014-05
Est. Completion 2015-02
Phase NA
Rex Medical

3 total trials

What the finished NCT02136004 record still lists

NCT02136004 is an interventional study that assigns participants to a tested intervention. The registered 220 participants enrollment target is mid-sized for trials with a published cap, above the 82-participant average among 17 other Surgical Wound trials with a reported enrollment target (168% higher).

The record links to 1 condition, with Surgical Wound appearing as the primary indexed condition, and to 1 intervention - of which Closer VSS is the first listed.

NCT02136004 lists 12 locations in 10 states (Pennsylvania, California, Colorado).

Frequently Asked Questions

What is clinical trial NCT02136004 about?

NCT02136004 is a clinical study titled "The Closer Trial: A Safety and Efficacy Study of the Rex Medical Vascular Sealing System". The objective of this trial is to demonstrate the safety and effectiveness of the Rex Medical Closer Vascular Sealing System in sealing femoral arterial access sites.

What is the current status of trial NCT02136004?

This trial is currently completed. It is a NA study. The enrollment target is 220 participants. The study started on 2014-05. Estimated completion is 2015-02.

What conditions does trial NCT02136004 study?

This clinical trial studies the following conditions: Surgical Wound.

What interventions are being tested in trial NCT02136004?

The interventions under investigation include: Closer VSS (DEVICE).

Who is sponsoring clinical trial NCT02136004?

This trial is sponsored by Rex Medical, which has 3 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02136004 being conducted?

This trial has 12 study locations across California, Colorado, District of Columbia, Louisiana, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Surgical Wound

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02136004's enrollment target sits among peer trials

220 2nd of 17 the highest of 17 other Surgical Wound trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Surgical Wound trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00920972 · 220 participants · Phase 1

    Campath/Fludarabine/Melphalan Transplant Conditioning for Non-Malignant Diseases

  • NCT01851642 · 220 participants

    Lung Disease and Its Affect on the Work of White Blood Cells in the Lungs

  • NCT02582021 · 220 participants

    WISE CVD - Continuation (WISE HFpEF)

  • NCT04067830 · 220 participants · Phase 2

    Respiratory Muscle Training Before Surgery in Preventing Lung Complications in Patients With Stage I-IIIB Lung Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02136004, the US trial registry maintained by the National Library of Medicine. NCT02136004 (mid enrollment · multi site footprint · completed) retrieved and formatted by PlainTrial, see methodology.